|
Site
|
HR positive*
|
HR negative*
|
≤ 50 y*
|
> 50 y*
|
|---|
| |
Cases/control (n/n)
|
OR (95% CI)
|
Cases/control (n/n)
|
OR (95% CI)
|
Cases/control (n/n)
|
OR (95% CI)
|
Cases/control (n/n)
|
OR (95% CI)
|
|---|
|
breast
|
12/16
|
1.69 (0.69 – 4.17)
|
9/16
|
3.59 (1.36 – 9.47)
|
12/16
|
2.23 (0.81 – 6.14)
|
14/16
|
2.43 (0.73 – 8.20)
|
|
Lung
|
17/13
|
3.37 (1.45 – 7.82)
|
4/13
|
1.30 (0.33 – 5.14)
|
11/13
|
2.01 (0.70 – 5.79)
|
10/13
|
3.24 (0.85 – 12.42)
|
|
Esophagus
|
7/7
|
1.56 (0.53 – 4.55)
|
11/7
|
6.19 (2.30 – 16.71)
|
10/7
|
2.64 (0.81 – 8.66)
|
8/7
|
2.50 (0.65 – 9.67)
|
|
Stomach
|
15/17
|
1.69 (0.80 – 3.60)
|
4/17
|
0.65 (0.18 – 2.39)
|
8/17
|
1.10 (0.40 – 3.03)
|
11/17
|
1.49 (0.51 – 4.32)
|
|
Intestine
|
6/8
|
1.21 (0.37 – 3.95)
|
1/8
|
0.55 (0.06 – 4.68)
|
4/8
|
0.72 (0.15 – 3.36)
|
3/8
|
1.16 (0.22 – 6.11)
|
|
Liver
|
6/5
|
2.29 (0.68 – 7.70)
|
4/5
|
2.95 (0.74 – 11.84)
|
4/5
|
1.66 (0.37 – 7.53)
|
6/5
|
2.82 (0.55 – 14.58)
|
|
Pancreas
|
4/5
|
1.53 (0.40 – 5.84)
|
2/5
|
1.57 (0.28 – 8.66)
|
4/5
|
5.07 (0.56 – 45.84)
|
2/5
|
0.51 (0.09 – 2.91)
|
|
Gallbladder
|
1/2
|
2.14 (0.13 – 35.41)
|
/
|
/
|
/
|
/
|
/
|
/
|
|
Larynx
|
4/2
|
5.19 (0.53 – 50.70)
|
/
|
/
|
/
|
/
|
2/2
|
1.83 (0.16 – 20.55)
|
|
Bladder
|
1/5
|
0.41 (0.05 – 3.71)
|
/
|
/
|
1/5
|
0.39 (0.04 – 3.81)
|
/
|
/
|
|
Kidney
|
2/1
|
3.12 (0.28 – 35.11)
|
/
|
/
|
2/1
|
1.93 (0.17 – 21.76)
|
/
|
/
|
|
Prostate
|
1/2
|
2.78 (0.17 – 46.34)
|
/
|
/
|
/
|
/
|
/
|
/
|
|
Uterus
|
4/3
|
3.23 (0.58 – 17.98)
|
3/3
|
6.92 (1.12 – 42.89)
|
2/3
|
1.11 (0.15 – 8.11)
|
/
|
/
|
|
Appendix
|
1/2
|
1.83 (0.11 – 30.22)
|
1/2
|
6.01 (0.36 – 101.25)
|
/
|
/
|
1/2
|
0.99 (0.06 – 16.34)
|
|
Lymphoma
|
4/3
|
5.26 (0.54 – 51.20)
|
1/3
|
4.64 (0.28 – 78.24)
|
2/3
|
1.37 (0.09 – 22.14)
|
/
|
/
|
|
Digestive tract
|
27/30
|
1.57 (0.89 – 2.77)
|
16/30
|
2.05 (1.03 – 4.10)
|
22/30
|
1.49 (0.74 – 3.00)
|
21/30
|
1.63 (0.77 – 3.49)
|
|
Digestive system
|
37/39
|
1.79 (1.09 – 2.93)
|
22/39
|
2.29 (1.26 – 4.17)
|
31/39
|
1.88 (1.03 – 3.43)
|
28/39
|
1.67 (0.86 – 3.25)
|
|
Urinary system
|
4/8
|
1.19 (0.33 – 4.31)
|
/
|
/
|
4/8
|
1.12 (0.27 – 4.58)
|
/
|
/
|
|
Hematological system
|
4/6
|
1.78 (0.35 – 8.94)
|
2/6
|
3.02 (0.48 – 18.88)
|
3/6
|
0.75 (0.12 – 4.64)
|
/
|
/
|
|
Gynecology
|
5/5
|
2.78 (0.65 – 11.87)
|
4/5
|
6.79 (1.46 – 31.65)
|
3/5
|
1.74 (0.28 – 10.66)
|
6/5
|
6.16 (0.73 – 52.15)
|
|
Two or more histories#
|
4/11
|
0.96 (0.27 – 3.39)
|
1/11
|
0.58 (0.07 – 4.92)
|
/
|
/
|
5/11
|
1.54 (0.35 – 6.65)
|
|
All sites#
|
73/70
|
2.36 (1.60 – 3.47)
|
32/70
|
2.29 (1.38 – 3.78)
|
58/70
|
1.92 (1.21 – 3.05)
|
48/70
|
2.39 (1.36 – 4.20)
|
-
HR, Hormone receptor; *Adjusted for age, age at menarche, childbearing, menopause status; #family history of breast cancer was excluded; bold data reflected P < 0.05.
